Multimodality PET/MRI agents targeted to activated macrophages Topical Issue on Metal-Based MRI Contrast Agents. Guest editor: Valerie C. Pierre

Chuqiao Tu, Thomas S C Ng, Russell E. Jacobs, Angelique Y. Louie

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The recent emergence of multimodality imaging, particularly the combination of PET and MRI, has led to excitement over the prospect of improving detection of disease. Iron oxide nanoparticles have become a popular platform for the fabrication of PET/MRI probes owing to their advantages of high MRI detection sensitivity, biocompatibility, and biodegradability. In this article, we report the synthesis of dextran-coated iron oxide nanoparticles (DIO) labeled with the positron emitter 64Cu to generate a PET/MRI probe, and modified with maleic anhydride to increase the negative surface charge. The modified nanoparticulate PET/MRI probe (MDIO-64Cu-DOTA) bears repetitive anionic charges on the surface that facilitate recognition by scavenger receptor type A (SR-A), a ligand receptor found on activated macrophages but not on normal vessel walls. MDIO-64Cu-DOTA has an average iron oxide core size of 7-8 nm, an average hydrodynamic diameter of 62.7 nm, an r 1 relaxivity of 16.8 mM-1 s-1, and an r 2 relaxivity of 83.9 mM-1 s-1 (37 C, 1.4 T). Cell studies confirmed that the probe was nontoxic and was specifically taken up by macrophages via SR-A. In comparison with the nonmodified analog, the accumulation of MDIO in macrophages was substantially improved. These characteristics demonstrate the promise of MDIO-64Cu-DOTA for identification of vulnerable atherosclerotic plaques via the targeting of macrophages.

Original languageEnglish (US)
Pages (from-to)247-258
Number of pages12
JournalJournal of Biological Inorganic Chemistry
Volume19
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Macrophages
Magnetic resonance imaging
Contrast Media
Metals
Nanoparticles
Maleic Anhydrides
Scavenger Receptors
Atherosclerotic Plaques
Hydrodynamics
Dextrans
Biodegradability
Positrons
Surface charge
Biocompatibility
Electrons
Ligands
Imaging techniques
Fabrication
ferric oxide

Keywords

  • Inflammation
  • Iron
  • Macrophages
  • MRI contrast agents
  • Nanoparticles

ASJC Scopus subject areas

  • Biochemistry
  • Inorganic Chemistry

Cite this

Multimodality PET/MRI agents targeted to activated macrophages Topical Issue on Metal-Based MRI Contrast Agents. Guest editor : Valerie C. Pierre. / Tu, Chuqiao; Ng, Thomas S C; Jacobs, Russell E.; Louie, Angelique Y.

In: Journal of Biological Inorganic Chemistry, Vol. 19, No. 2, 02.2014, p. 247-258.

Research output: Contribution to journalArticle

@article{bedaa2ae1e2b46a8901efdcff7492bff,
title = "Multimodality PET/MRI agents targeted to activated macrophages Topical Issue on Metal-Based MRI Contrast Agents. Guest editor: Valerie C. Pierre",
abstract = "The recent emergence of multimodality imaging, particularly the combination of PET and MRI, has led to excitement over the prospect of improving detection of disease. Iron oxide nanoparticles have become a popular platform for the fabrication of PET/MRI probes owing to their advantages of high MRI detection sensitivity, biocompatibility, and biodegradability. In this article, we report the synthesis of dextran-coated iron oxide nanoparticles (DIO) labeled with the positron emitter 64Cu to generate a PET/MRI probe, and modified with maleic anhydride to increase the negative surface charge. The modified nanoparticulate PET/MRI probe (MDIO-64Cu-DOTA) bears repetitive anionic charges on the surface that facilitate recognition by scavenger receptor type A (SR-A), a ligand receptor found on activated macrophages but not on normal vessel walls. MDIO-64Cu-DOTA has an average iron oxide core size of 7-8 nm, an average hydrodynamic diameter of 62.7 nm, an r 1 relaxivity of 16.8 mM-1 s-1, and an r 2 relaxivity of 83.9 mM-1 s-1 (37 C, 1.4 T). Cell studies confirmed that the probe was nontoxic and was specifically taken up by macrophages via SR-A. In comparison with the nonmodified analog, the accumulation of MDIO in macrophages was substantially improved. These characteristics demonstrate the promise of MDIO-64Cu-DOTA for identification of vulnerable atherosclerotic plaques via the targeting of macrophages.",
keywords = "Inflammation, Iron, Macrophages, MRI contrast agents, Nanoparticles",
author = "Chuqiao Tu and Ng, {Thomas S C} and Jacobs, {Russell E.} and Louie, {Angelique Y.}",
year = "2014",
month = "2",
doi = "10.1007/s00775-013-1054-9",
language = "English (US)",
volume = "19",
pages = "247--258",
journal = "Journal of Biological Inorganic Chemistry",
issn = "0949-8257",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Multimodality PET/MRI agents targeted to activated macrophages Topical Issue on Metal-Based MRI Contrast Agents. Guest editor

T2 - Valerie C. Pierre

AU - Tu, Chuqiao

AU - Ng, Thomas S C

AU - Jacobs, Russell E.

AU - Louie, Angelique Y.

PY - 2014/2

Y1 - 2014/2

N2 - The recent emergence of multimodality imaging, particularly the combination of PET and MRI, has led to excitement over the prospect of improving detection of disease. Iron oxide nanoparticles have become a popular platform for the fabrication of PET/MRI probes owing to their advantages of high MRI detection sensitivity, biocompatibility, and biodegradability. In this article, we report the synthesis of dextran-coated iron oxide nanoparticles (DIO) labeled with the positron emitter 64Cu to generate a PET/MRI probe, and modified with maleic anhydride to increase the negative surface charge. The modified nanoparticulate PET/MRI probe (MDIO-64Cu-DOTA) bears repetitive anionic charges on the surface that facilitate recognition by scavenger receptor type A (SR-A), a ligand receptor found on activated macrophages but not on normal vessel walls. MDIO-64Cu-DOTA has an average iron oxide core size of 7-8 nm, an average hydrodynamic diameter of 62.7 nm, an r 1 relaxivity of 16.8 mM-1 s-1, and an r 2 relaxivity of 83.9 mM-1 s-1 (37 C, 1.4 T). Cell studies confirmed that the probe was nontoxic and was specifically taken up by macrophages via SR-A. In comparison with the nonmodified analog, the accumulation of MDIO in macrophages was substantially improved. These characteristics demonstrate the promise of MDIO-64Cu-DOTA for identification of vulnerable atherosclerotic plaques via the targeting of macrophages.

AB - The recent emergence of multimodality imaging, particularly the combination of PET and MRI, has led to excitement over the prospect of improving detection of disease. Iron oxide nanoparticles have become a popular platform for the fabrication of PET/MRI probes owing to their advantages of high MRI detection sensitivity, biocompatibility, and biodegradability. In this article, we report the synthesis of dextran-coated iron oxide nanoparticles (DIO) labeled with the positron emitter 64Cu to generate a PET/MRI probe, and modified with maleic anhydride to increase the negative surface charge. The modified nanoparticulate PET/MRI probe (MDIO-64Cu-DOTA) bears repetitive anionic charges on the surface that facilitate recognition by scavenger receptor type A (SR-A), a ligand receptor found on activated macrophages but not on normal vessel walls. MDIO-64Cu-DOTA has an average iron oxide core size of 7-8 nm, an average hydrodynamic diameter of 62.7 nm, an r 1 relaxivity of 16.8 mM-1 s-1, and an r 2 relaxivity of 83.9 mM-1 s-1 (37 C, 1.4 T). Cell studies confirmed that the probe was nontoxic and was specifically taken up by macrophages via SR-A. In comparison with the nonmodified analog, the accumulation of MDIO in macrophages was substantially improved. These characteristics demonstrate the promise of MDIO-64Cu-DOTA for identification of vulnerable atherosclerotic plaques via the targeting of macrophages.

KW - Inflammation

KW - Iron

KW - Macrophages

KW - MRI contrast agents

KW - Nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84893765376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893765376&partnerID=8YFLogxK

U2 - 10.1007/s00775-013-1054-9

DO - 10.1007/s00775-013-1054-9

M3 - Article

C2 - 24166283

AN - SCOPUS:84893765376

VL - 19

SP - 247

EP - 258

JO - Journal of Biological Inorganic Chemistry

JF - Journal of Biological Inorganic Chemistry

SN - 0949-8257

IS - 2

ER -